Position in IBRX
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$30,108,170
+$29,392,510 QoQ
Shares Held
3,925,446
+1551.0% QoQ
Ownership
0.375%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
7 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in IBRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026HRT FINANCIAL LP holds $421,739,007 across 198 Biotechnology names. IBRX ranks #2 (7.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
128,633 | $42,560,800 | |
| 2 | IBRX |
ImmunityBio, Inc.
This page
|
3,925,446 | $30,108,170 | |
| 3 | EXEL |
Exelixis, Inc.
|
460,585 | $19,754,490 | |
| 4 | IONS |
Ionis Pharmaceuticals Inc
|
252,250 | $18,941,452 | |
| 5 | MRNA |
Moderna, Inc.
|
368,421 | $18,715,786 | |
| 6 | ARGX |
Argenx SE
|
18,754 | $13,695,108 | |
| 7 | RARE |
Ultragenyx Pharmaceutical Inc.
|
613,229 | $12,847,147 | |
| 8 | IOVA |
Iovance Biotherapeutics, Inc.
|
3,486,299 | $12,236,909 |
All Filings in IBRX
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $30,108,170 | 3,925,446 | Shares | Defined | 2026-05-14 | |
| 2025-03-31 | $715,660 | 237,761 | Shares | Defined | 2025-05-15 | |
| 2024-06-30 | $428,382 | 67,782 | Shares | Defined | 2024-08-12 | |
| 2023-03-31 | $127,196 | 69,888 | Shares | Defined | 2023-05-12 | |
| 2022-06-30 | $203,547 | 54,717 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $212,293 | 37,842 | Shares | Defined | 2022-05-16 | |
| 2021-03-31 | $2,225,957 | 93,764 | Shares | Defined | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||